Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Menorrhagia × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 13 Cholangiocarcinoma 8 Barrett Esophagus 6 Pancreatic Neoplasms 5 Liver Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Lung Neoplasms 4 Thyroid Nodule 3 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Pain 2 Neoplasms 2 Hyperaldosteronism 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2 Squamous Intraepithelial Lesions 1 Papillary Thyroid Microcarcinoma 1 Pancreatic cancer, adult 1 Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1 Neuroma 1 Neuralgia 1 Neoplasm Micrometastasis 1 Myoma 1

Interventions

Uterine Myomectomy 4 Uterine Artery Embolization 2 pycnogenols 1 Radiofrequency Ablation 1 Endomet 1 Electrocoagulation 1 Cryosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡